1. Ивашкин В.Т. Основные понятия и положения фундаментальной иммунологии. Рос. журн. гастроэнтерол.,
 гепатол., колопроктол. 2008; 4: 4–13.
2. Кононов А.В. Воспаление как основа Helicobacter pylori–ассоциированных болезней: от гастрита – до рака желудка. Труды II съезда Российского общества патологоанатомов. М., 2006; с. 229–31.
3. Akhiani AA. The role of type–specific antibodies in colonization and infection by Helicobacter pylori. Curr Opin Infect Dis 2005; 18 (3): 223–7.
4. Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 2006; 19 (4): 597–613.
5. Allen LA, Beecher BR, Lynch JT. Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 2005; 174: 3658–67.
6. Amieva MR, El–Omar EM. Host–bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134 (1): 306–23.
7. Beswick EJ, Suarez G, Reyes VE. H. pylori and host interactions that influence pathogenesis. World J Gastroenterol 2006; 12 (35): 5599–605.
8. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Investig 2004; 113: 321–33.
9. Evans DJ et al. Characterization of a Helicobacter pylori neutrophil–activating protein. Infect Immun 1995; 63 (6): 2213–20.
10. El–Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48 (6): 743–7.
11. Schmausser B et al. Expression and subcellular distribution of toll–like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521–6.
12. Archimandritis A et al. Expression of HLA–DR, costimulatory molecules B7–1, B7–2, intercellular adhesion molecule–1 (ICAM–1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. Clin Exp Immunol 2000; 119: 464–71.
13. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117 (1): 60–1.
14. Backhed F et al. Gastric mucosal recognition of Helicobacter pylori is independent of Toll–like receptor 4. J Infect Dis 2003; 187: 829–36.
15. D'Elios MM et al. Helicobacter pylori and gastric autoimmunity. Microbes Infect 2004; 6 (15): 1395–401.
16. Torok AM et al. Helicobacter pylori Induces Interleukin–8 Secretion by Toll–Like Receptor 2– and Toll–Like Receptor. Infect Immun 2005; 73 (3): 1523–31.
17. Fan X et al. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol 2000; 165: 1918–24.
18. Beswick EJ et al. Helicobacter pylori–induced IL–8 production by gastric epithelial cells up–regulates CD74 expression. J Immunol 2005; 175: 171–6.
19. Lundgren AC et al. Helicobacter pylori–specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun 2005; 73: 5612–9.
20. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19 (3): 449–90.
21. Bamford KB et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori infection have a T helper cell 1 phenotype. Gastroenterology 1998; 114: 482–92.
22. Malfertheiner P, Malfertheiner P, Mégraud F, O'Morain 
C. Guidelines for the Management of Helicobacter 
pylori Infection Summary of the Maastricht–3 2005 Consensus Report. Вusiness briefing: Еuropean gastroenterology review 2005; р. 59–60.
23. Amedei A et al. Molecular mimicry between Helicobacter pylori antigens and H+,K+–adenosine triphosphatase 
in human gastric autoimmunity. J Exp Med 2003; 1998 (8): 1147–56.
24. Viala J et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166–74.
25. O'Keeffe J, Moran AP. Conventional, Regulatory, and Unconventional T Cells in the Immunologic Response to Helicobacter pylori. Blackwell Publishing Ltd, Helicobacter 2008; 13: 1–19.
26. Peek R, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208 (2): 233–48.
27. Peek RM. Events at the Host–Microbial Interface 
of the Gastrointestinal Tract. The pathogenesis of Helicobacter pylori persistence. Am J Physiol Gastrointest Liver Physiol 2005; 289 (1): 8–12.
28. Peсa AS. Genetic factors determining the host response to Helicobacter pylori. World J Gastroenterol 2000; 6 (5): 624–5.
29. Suarez G, Reyes VE, Beswick EJ. Immune response to H pylori. World J Gastroenterol 2006; 12 (35): 5593–8.
30. Blaser MJ. The biology of cag in the Helicobacter pylori–human interaction. Gastroenterology 2005; 128: 1512–5.
31. Tytgat GNJ. Ulcers and gastritis endoscopy 2000; 32 (2).
32. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion 2006; 73: 116–23.